Epidemiology of Road Traffic Accidents in Riyadh Region in the Last Five Years (2019-2023)

August 12, 2024 updated by: Mubarak Mohammed Saleh Alrakah, Assiut University

The findings arising from the proposed study will spot light on the issue of road traffic accidents in Riyadh Region which will help stakeholders to design proper plans and strategies of prevention and control of this issue. This will minimize the toll and burden of road traffic accidents in Riyadh Region.

To highlight the magnitude of the problem of road traffic accidents in Riyadh Region in the last five years (2019-2023), To identify the demographic characteristics of the victims involved in accidents throughout the last five years in Riyadh Region, To estimate the trend and seasonal variations of road traffic accidents Riyadh Region.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Road traffic accidents (RTAs) have become a significant public health concern that requires quick attention. RTAs cause the bulk of hospital admissions due to trauma globally. The incidence of trauma caused by RTA was the highest cause of trauma-related admission (62.5%). These RTAs have the potential to cause harm to one or more bodily parts, and in extreme circumstances, they may even be fatal. They are a major contributor to early-life impairment and death. Saudi Arabia has the greatest RTA-associated mortality. RTAs account for 13% of the Saudi population's disability-adjusted life years (DALYs).

The World Health Organization (WHO) estimates that 1.25 million people die in RTAs each year, despite constant attempts to lessen the toll of these incidents on healthcare systems. Twenty to fifty million individuals experience non-fatal injuries, such as trauma and disability, necessitating extended hospital admissions. By 2030, road traffic accidents are predicted to rank the seventh cause of mortality, if the ongoing efforts to enhance healthcare are not made.

Depending on the kind of harm, RTIs can be classified into several categories. RTIs can be of any kind, ranging from cuts, piercings, and crush wounds to internal organ damage, fractures, and amputations. These injuries might impact almost any part of the body. The lower limbs were the most damaged body region in victims of RTAs, followed by the chest, upper limbs, head, and spine, as concluded by a study done between July 2014 and July 2017.

According to different researches, bigger, substantial organs, including the spleen, liver, and kidneys, are most frequently harmed by intra-abdominal lesions brought on by RTAs. There may be several pros to this classification of RTI frequency based on the type of injury and the body location impacted. According to a published research, individuals with serious brain and pelvic injuries have a high death risk. As a result, the clinicians working in the emergency room could better assess the seriousness of each individual emergency case and properly prioritize them.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Assiut, Egypt
        • Recruiting
        • Assiut University
        • Contact:
        • Sub-Investigator:
          • Mohammad H Qayed, MD
        • Sub-Investigator:
          • Ekram M Khalek, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This cross section study will be conducted on all the Road Traffic Accidents victims; who attended the emergency room or admitted to the hospital during the study period

Description

Inclusion Criteria:

-All the Road Traffic Accidents victims; who attended the emergency room or admitted to the hospital during the study period.

Exclusion Criteria:

-Any injury on the road without involvement of a vehicle (e.g. a person slipping and falling on the road and sustaining injury) or injury involving a stationary vehicle (e.g. persons being injured while washing or loading a vehicle).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Road Traffic Accidents
Time Frame: Five years from the start of the study
Prevalence of Road Traffic Accidents will be recorded in the Riyadh Region in the Last Five Years.
Five years from the start of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Causes of Road Traffic Accidents
Time Frame: Five years from the start of the study
Causes of Road Traffic Accidents will be recorded such as dangerous overtaking / lane cutting, drunken driving, over crowding and over loading, lack of driving skills and inadequate knowledge of traffic discipline.
Five years from the start of the study
Complication
Time Frame: Five years from the start of the study
Complication will be recorded such as physical injuries, psychological trauma, financial strain, legal issues, and disruptions to traffic flow.
Five years from the start of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

August 12, 2024

First Submitted That Met QC Criteria

August 12, 2024

First Posted (Actual)

August 14, 2024

Study Record Updates

Last Update Posted (Actual)

August 14, 2024

Last Update Submitted That Met QC Criteria

August 12, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 04-2024-200850

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

IPD Sharing Time Frame

After the end of study for one year.

IPD Sharing Access Criteria

The data will be available upon a reasonable request from the corresponding author.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epidemiology

Clinical Trials on Data collection

Subscribe